Category: Health Policy

Drug discovery speed improves 5,000-fold as Talus Bio skips protein folding to target previously undruggable proteins in their innovative screening...

Expanded pharma tariffs now target mid-sized and smaller drugmakers, raising R&D costs and industry concerns over innovation and pricing strategies.

The FDA has finalized its guidance on written responses and meeting types, revising circumstances for INTERACT meetings under the Prescription...

Peptides face metabolic stability challenges in treating diseases like obesity and cardiovascular disorders with peptide therapeutics.

Glenmark Pharmaceuticals has introduced Telma AM Biso , a fixed-dose combination tablet containing telmisartan, amlodipine, and bisoprolol for treating.

Tenecteplase stroke treatment may significantly reduce door-to-needle times compared to alteplase, improving outcomes for acute ischemic stroke patients.

Medicaid plans may face behavioral health barriers, including workforce and data sharing issues, affecting care integration and support for enrolled...

Vanderbilt informatics leader Peter Embí is named next NLM director, bringing decades of expertise in clinical research, AI, and data-driven...

Virtual CKD management programs fail to slow disease progression or reduce costs, according to a Peterson Health Technology Institute report.

Korean obesity experts call for national health insurance coverage of GLP-1 drugs amid concerns over misuse by healthy individuals.